Arcutis Biotherapeutics, Inc. ARQT Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s earnings yield?
- Arcutis Biotherapeutics, Inc. (ARQT) reported earnings yield of -2% in Q3 2025.
- How has Arcutis Biotherapeutics, Inc.'s earnings yield changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s earnings yield increased by 89.1% year-over-year, from -18% to -2%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s earnings yield?
- Over 4 years (2020 to 2024), Arcutis Biotherapeutics, Inc.'s earnings yield has grown at a -2.7% compound annual growth rate (CAGR), from -9.6% to -8.6%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.